Therefore, to explore the impact of MEN1611 treatment on this pathway in NSCLC with a wild-type PIK3CA gene, the phosphorylation status of known PI3K downstream targets was examined. This evidence concerns the gene PIK3CA and non-small cell lung carcinoma.